DALIRESP vs ROFLUMILAST

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Attribute	DALIRESP	ROFLUMILAST
Rating	70/100	66/100
Pharmacy pays	~$10.09 /30	~$10.09 /30
Type	RX	RX
Active ingredient	ROFLUMILAST	ROFLUMILAST
Manufacturer	Astrazeneca	Torrent
Dosage forms	Tablet	Tablet
Drug class	Phosphodiesterase 4 Inhibitor	Phosphodiesterase 4 Inhibitor
Boxed warning	None	None
Treats	Chronic Obstructive Pulmonary Disease	Chronic Obstructive Pulmonary Disease

daliresp roflumilast

Rating

70/100

66/100

Pharmacy pays

~$10.09 /30

Type

Active ingredient

ROFLUMILAST

Manufacturer

Astrazeneca

Torrent

Dosage forms

Tablet

Drug class

Phosphodiesterase 4 Inhibitor

Boxed warning

None

Treats

Chronic Obstructive Pulmonary Disease

Frequently asked questions

Which is better-rated, Daliresp or Roflumilast?

By our independent rating, Daliresp scores higher — 3.5 vs 3.3 out of 5 for Roflumilast. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Daliresp or Roflumilast?

Pharmacies pay about the same to acquire either one — roughly $10.09 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Daliresp and Roflumilast?

Both Daliresp and Roflumilast share the active ingredient Roflumilast.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.